DE69942305D1 - Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil - Google Patents

Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil

Info

Publication number
DE69942305D1
DE69942305D1 DE69942305T DE69942305T DE69942305D1 DE 69942305 D1 DE69942305 D1 DE 69942305D1 DE 69942305 T DE69942305 T DE 69942305T DE 69942305 T DE69942305 T DE 69942305T DE 69942305 D1 DE69942305 D1 DE 69942305D1
Authority
DE
Germany
Prior art keywords
glp
exendin
derivatives
extended durability
profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942305T
Other languages
English (en)
Inventor
Liselotte Bjerre Knudsen
Per Olaf Huusfeldt
Per Franklin Nielsen
Kjeld Madsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority claimed from PCT/DK1999/000086 external-priority patent/WO1999043708A1/en
Application granted granted Critical
Publication of DE69942305D1 publication Critical patent/DE69942305D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69942305T 1998-02-27 1999-02-25 Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil Expired - Lifetime DE69942305D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK27498 1998-02-27
PCT/DK1999/000086 WO1999043708A1 (en) 1998-02-27 1999-02-25 Glp-1 derivatives of glp-1 and exendin with protracted profile of action

Publications (1)

Publication Number Publication Date
DE69942305D1 true DE69942305D1 (de) 2010-06-10

Family

ID=8091706

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942305T Expired - Lifetime DE69942305D1 (de) 1998-02-27 1999-02-25 Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil

Country Status (4)

Country Link
EP (1) EP1840134B1 (de)
AT (1) ATE466026T1 (de)
DE (1) DE69942305D1 (de)
ZA (1) ZA991571B (de)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5614492A (en) * 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
ATE110083T1 (de) 1986-05-05 1994-09-15 Gen Hospital Corp Insulinotropes hormon.
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
WO1990011296A1 (en) * 1989-03-20 1990-10-04 The General Hospital Corporation Insulinotropic hormone
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
DK36492D0 (da) 1992-03-19 1992-03-19 Novo Nordisk As Praeparat
DK36392D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
US5424286A (en) * 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
WO1997046584A1 (de) * 1996-06-05 1997-12-11 Boehringer Mannheim Gmbh Exendin-analoga, verfahren zu deren herstellung und diese enthaltende arzneimittel
UA72181C2 (uk) * 1996-08-30 2005-02-15 Ново Нордіск А/С Похідна глюкагоноподібного пептиду-1 (варіанти), фармацевтична композиція та спосіб одержання лікувального засобу (варіанти), спосіб лікування діабету (варіанти) і ожиріння

Also Published As

Publication number Publication date
EP1840134A2 (de) 2007-10-03
EP1840134B1 (de) 2016-04-13
EP1840134A3 (de) 2008-01-23
ZA991571B (en) 1999-09-02
ATE466026T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
BR1100853A (pt) Composto, composição farmacêutica, e composição veterinária
ATE219938T1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
DE59510421D1 (de) Substituierte Pyridylpyrazole
ATE129697T1 (de) 9-amino-7-substituierte-6-desmethyl-6- desoxytetracyclin.
DK1200418T3 (da) Nematodicide trifluorbutener
ATE240953T1 (de) Carbazolcarboxamide als 5-ht1f agonisten
ES2064642T3 (es) Peptidos hemorreguladores.
BR0110439A (pt) Materiais corantes de oxidação
MXPA03008250A (es) Nuevos derivados de diaminopirazol y colorantes que contienen estos compuestos.
DE58904434D1 (de) Organische derivate von rheniumoxiden sowie ihre herstellung und verwendung zur metathese von olefinen.
DE69802884D1 (de) Zusammensetzung zum oxidativen Färben von Keratinfasern, die als Oxidationsbase ein Aminosäurederivat enthält, und neue Aminosäurederivate.
DE69942305D1 (de) Derivate von glp-1 und exendin mit verlängertem wirkdauer-profil
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
DK0432898T3 (da) Glutarsyrederivater og fremstillingen deraf
ATE253562T1 (de) Substituierte 2,4-diamino-1,3,5-triazine
DE69408622D1 (de) Hydrazone von Indantrione und ihre therapeutische Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition